Chemkart India Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹312 Cr
- P/E
- 9.71
- ROE
- 21.48%
- PEG
- 0.26
- Price to sales
- 0.99
- Debt to equity
- 0.14
- 52W high / low
- ₹269 / ₹87.6
- EBITDA margin
- 13.67%
- Net profit margin
- 9.15%
- Promoter holding
- 74.88%
- Sales (last year)
- ₹317 Cr
Incorporated in 2020, Chemkart India Limited, based in Mumbai, is a B2B nutraceutical ingredient distributor and processor.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Food Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹23,562 Cr | 134.3 | |
| 2 | 40%+ | Up 2%+ | ₹435 Cr | 7.5 | |
| 3 | 40%+ | Up 2%+ | ₹413 Cr | 72.6 | |
| 4 | 40%+ | Flat | ₹1,012 Cr | 46.0 | |
| 5 | 40%+ | Flat | ₹148 Cr | 9.8 | |
| 6 | 20–40% | Up 2%+ | ₹670 Cr | 48.3 |
Sign up free to see every company in the sector ranking and track Chemkart India.
Pro shows every company guiding 40%+ revenue growth →Full Food Products rankingFinancials of Chemkart India
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Chemkart India
Quarterly Results
Quarter-by-quarter operating performance
Financials of Chemkart India
Profit & Loss
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 87 | 131 | 132 | 203 | 215 |
| Expenses + | 80 | 120 | 111 | 171 | 187 |
| Operating Profit | 7 | 11 | 21 | 33 | 28 |
| OPM % | 8% | 8% | 16% | 16% | 13% |
| Other Income + | 0 | 0 | 1 | 2 | 1 |
| Interest | 0 | 1 | 1 | 2 | 1 |
| Depreciation | 0 | 0 | 0 | 1 | 0 |
| Profit before tax | 7 | 11 | 20 | 33 | 27 |
| Tax % | 25% | 27% | 27% | 26% | 27% |
| Net Profit + | 5 | 8 | 15 | 24 | 20 |
| EPS in Rs | 40.38 | 56.45 | 107.00 | 25.55 | 16.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Chemkart India
Balance Sheet
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 10 | 12 |
| Reserves | 5 | 13 | 28 | 44 | 118 |
| Borrowings + | 6 | 11 | 13 | 17 | 5 |
| Other Liabilities + | 12 | 12 | 12 | 16 | 22 |
| Total Liabilities | 25 | 37 | 54 | 86 | 157 |
| Fixed Assets + | 1 | 6 | 5 | 9 | 8 |
| CWIP | 0 | 0 | 0 | 0 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 24 | 32 | 48 | 77 | 144 |
| Total Assets | 25 | 37 | 54 | 86 | 157 |
Financials of Chemkart India
Cash Flows
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -6 | 0 | -0 | 4 | -3 |
| Cash from Investing Activity + | -1 | -5 | -0 | -4 | -5 |
| Cash from Financing Activity + | 7 | 5 | 0 | 3 | 43 |
| Net Cash Flow | -0 | 0 | -0 | 3 | 36 |
| Free Cash Flow | -7 | -5 | -0 | -0 | -8 |
| CFO/OP | -85% | 34% | 24% | 31% | 18% |
Financials of Chemkart India
Ratios
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 80 | 62 | 87 | 82 | 85 |
| Inventory Days | 9 | 25 | 27 | 50 | 71 |
| Days Payable | 41 | 34 | 33 | 23 | 38 |
| Cash Conversion Cycle | 49 | 53 | 81 | 109 | 119 |
| Working Capital Days | 28 | 25 | 66 | 75 | 106 |
| ROCE % | 58% | 63% | 62% | 28% |
Continue your research
What Chemkart India's management said in earlier quarters
Others in Food Products this season
- Zydus Wellness (Q2 FY27)
Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26. Key investor presentation takeaways from Zydus Wellness Ltd's Q2 FY27
- Hoac Foods (Q2 FY27)
Revenue from operations (gross) for the quarter ended September 30, 2026, is ₹2,326.15 lakh (Standalone) and ₹2,314.04 lakh (Consolidated). Key results statemen
- Narmada Agrobase (Q2 FY27)
EBITDA for the quarter ended September 30, 2026: ₹2303.54 lakhs, up from ₹2153.41 lakhs in the same quarter last year (YoY increase). Key results statement take
- Dangee Dums (Q2 FY27)
700.42 lakhs for the quarter ended September 30, 2025, reflecting a year-on-year increase of approximately 13.37%. Key results statement takeaways from Dangee D